These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36029126)

  • 61. REPAIRx, a specific yet highly efficient programmable A > I RNA base editor.
    Liu Y; Mao S; Huang S; Li Y; Chen Y; Di M; Huang X; Lv J; Wang X; Ge J; Shen S; Zhang X; Liu D; Huang X; Chi T
    EMBO J; 2020 Nov; 39(22):e104748. PubMed ID: 33058207
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CRISPR-Cas9 off-targeting assessment with nucleic acid duplex energy parameters.
    Alkan F; Wenzel A; Anthon C; Havgaard JH; Gorodkin J
    Genome Biol; 2018 Oct; 19(1):177. PubMed ID: 30367669
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Optimization of genome editing through CRISPR-Cas9 engineering.
    Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
    Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Design of Guide RNA for CRISPR/Cas Plant Genome Editing].
    Gerashchenkov GA; Rozhnova NA; Kuluev BR; Kiryanova OY; Gumerova GR; Knyazev AV; Vershinina ZR; Mikhailova EV; Chemeris DA; Matniyazov RT; Baimiev AK; Gubaidullin IM; Baimiev AK; Chemeris AV
    Mol Biol (Mosk); 2020; 54(1):29-50. PubMed ID: 32163387
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A viral guide RNA delivery system for CRISPR-based transcriptional activation and heritable targeted DNA demethylation in Arabidopsis thaliana.
    Ghoshal B; Vong B; Picard CL; Feng S; Tam JM; Jacobsen SE
    PLoS Genet; 2020 Dec; 16(12):e1008983. PubMed ID: 33315895
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Efficient In Vivo Liver-Directed Gene Editing Using CRISPR/Cas9.
    Singh K; Evens H; Nair N; Rincón MY; Sarcar S; Samara-Kuko E; Chuah MK; VandenDriessche T
    Mol Ther; 2018 May; 26(5):1241-1254. PubMed ID: 29599079
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mismatch Intolerance of 5'-Truncated sgRNAs in CRISPR/Cas9 Enables Efficient Microbial Single-Base Genome Editing.
    Lee HJ; Kim HJ; Lee SJ
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208669
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Engineered Extracellular Vesicle-Delivered CRISPR/CasRx as a Novel RNA Editing Tool.
    Li T; Zhang L; Lu T; Zhu T; Feng C; Gao N; Liu F; Yu J; Chen K; Zhong J; Tang Q; Zhang Q; Deng X; Ren J; Zeng J; Zhou H; Zhu J
    Adv Sci (Weinh); 2023 Apr; 10(10):e2206517. PubMed ID: 36727818
    [TBL] [Abstract][Full Text] [Related]  

  • 69. CRISPRon/off: CRISPR/Cas9 on- and off-target gRNA design.
    Anthon C; Corsi GI; Gorodkin J
    Bioinformatics; 2022 Dec; 38(24):5437-5439. PubMed ID: 36271848
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Targeted Nucleotide Editing Technologies for Microbial Metabolic Engineering.
    Arazoe T; Kondo A; Nishida K
    Biotechnol J; 2018 Sep; 13(9):e1700596. PubMed ID: 29862665
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Simplified CRISPR-Mediated DNA Editing in Multicellular Eukaryotes.
    Kumar R; Tiwari K; Saudagar P
    Methods Mol Biol; 2023; 2575():241-260. PubMed ID: 36301478
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Therapeutic Genome Editing and its Potential Enhancement through CRISPR Guide RNA and Cas9 Modifications.
    Batzir NA; Tovin A; Hendel A
    Pediatr Endocrinol Rev; 2017 Jun; 14(4):353-363. PubMed ID: 28613045
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A lentivirus-based system for Cas9/gRNA expression and subsequent removal by Cre-mediated recombination.
    Carpenter MA; Law EK; Serebrenik A; Brown WL; Harris RS
    Methods; 2019 Mar; 156():79-84. PubMed ID: 30578845
    [TBL] [Abstract][Full Text] [Related]  

  • 74. CRISPR-Cas9-mediated genome editing and guide RNA design.
    Wiles MV; Qin W; Cheng AW; Wang H
    Mamm Genome; 2015 Oct; 26(9-10):501-10. PubMed ID: 25991564
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing.
    Mok BY; de Moraes MH; Zeng J; Bosch DE; Kotrys AV; Raguram A; Hsu F; Radey MC; Peterson SB; Mootha VK; Mougous JD; Liu DR
    Nature; 2020 Jul; 583(7817):631-637. PubMed ID: 32641830
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria.
    Grenier F; Lucier JF; Rodrigue S
    Methods Mol Biol; 2015; 1334():233-44. PubMed ID: 26404154
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In Silico Meets In Vivo: Towards Computational CRISPR-Based sgRNA Design.
    Chuai GH; Wang QL; Liu Q
    Trends Biotechnol; 2017 Jan; 35(1):12-21. PubMed ID: 27418421
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Targeted Base Editing via RNA-Guided Cytidine Deaminases in Xenopus laevis Embryos.
    Park DS; Yoon M; Kweon J; Jang AH; Kim Y; Choi SC
    Mol Cells; 2017 Nov; 40(11):823-827. PubMed ID: 29179261
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Development of gene editing strategies for human β-globin (HBB) gene mutations.
    Kalkan BM; Kala EY; Yuce M; Karadag Alpaslan M; Kocabas F
    Gene; 2020 Apr; 734():144398. PubMed ID: 31987908
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Polycistronic tRNA and CRISPR guide-RNA enables highly efficient multiplexed genome engineering in human cells.
    Dong F; Xie K; Chen Y; Yang Y; Mao Y
    Biochem Biophys Res Commun; 2017 Jan; 482(4):889-895. PubMed ID: 27890617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.